COMMUNITY

ÃÖ°íÀÇ ±â¼ú·Â°ú ÃÖ»óÀÇ Ç°Áú,
ÂøÇÑ °¡°ÝÀ¸·Î º¸´äÇÏ¿© µå¸®°Ú½À´Ï´Ù.

Ä¿¹Â´ÏƼ
Community

  • Ȩ
  • Ä¿¹Â´ÏƼ
  • ÇÁ·Î¸ð¼Ç

ÇÁ·Î¸ð¼Ç

ÇÑÁ¤±â°£ ¾Æ¹Ù¹ÙÀÌ¿À Á¦°øÇϴ Ưº°ÇÑ °¡°Ý
Á¦¸ñ [Genscript] What is the effective coronavirus test method?
ÀÛ¼ºÀÚ abbabio
ÀÛ¼ºÀÏÀÚ 2020-03-24
Á¶È¸¼ö 513
 
 Genscript View online › 
Proteins and Antibodies for COVID-19 Research
Learn More
COVID-19
Coronavirus is now a global level risk. Many cases seem to be spread from asymptomatic patients.
There's a huge drawback for nucleic acid detection for SARS-CoV-2. It only gives a positive result when the virus is still present. Antibody tests, also called serological tests, can confirm whether someone was infected before. That is to say, the antibody test result could be positive even if a PCR test of a suspected case is negative.
According to the latest coronavirus diagnosis guidance in China, suspected cases can be ruled out if the test results meet the two conditions.
The nucleic acid test is negative twice in a row. (The sampling time interval is at least 24 hours.)
SARS-CoV-2 specific antibodies IgM and IgG are still negative 7 days after onset of the disease.
It's crucial to develop accurate tests to contain the outbreak. GenScript is now providing a series of coronavirus proteins and antibodies to support the development of detection kits, vaccines and therapeutic drugs.
Check Complete Product List
 
Hot Products
SARS-CoV-2 S protein (RBD)
Cat.no: Z03479
Source: Sf9 insect cells
ACE2
EC50<100ng/ml Measured by its binding ability in a functional ELISA
*SARS-CoV-2 Spike S1-RBD IgG ELISA Detection Kit
Cat.no: L00830
*SARS-CoV-2 Spike S1-RBD IgG&IgM ELISA Detection Kit
Cat.no: L00831
S1-RBD
 *Research Use Only
 
Connect With UsLinkedinLinkedInFacebookFacebookTwitterTwitter
 
Copyright 2020 GenScript USA Inc. All rights reserved.
If you prefer not to receive GenScript News in Email, please
unsubscribe.
860 Centennial Avenue | Piscataway | NJ 088854 | USA
÷ºÎÆÄÀÏ